U.S. pharma large copyright scrapped two experimental weight loss pills final yr—a at the time-daily capsule, lotiglipron, resulting from elevated liver enzymes in addition to a twice-daily pill, danuglipron, because of robust Negative effects—but CEO Albert Bourla has mentioned the